FDA clears neuromonitoring software from Astro-Med unit

01/22/2009 | Pharmaceutical Business Review Online

The FDA has granted 510(k) clearance to Grass Technologies Product Group for its neuromonitoring software system. Called Grass Neurotrac III, the product allows clinicians to monitor long-term changes in brain activity by recording electroencephalograms and computed EEG trends over prolonged periods.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ